⚠️ Warnings
Pregnancy
Pregnancy:
Do not use Trifarotene if you are pregnant or planning to become pregnant. Your doctor can provide you with further information. If you become pregnant while using Trifarotene, you must discontinue treatment and inform your doctor immediately.
Breast-feeding
Breast-feeding:
When using Trifarotene, there is a risk that the active substance in the cream may pass into breast milk; therefore, the risk to the newborn/infant cannot be excluded. Together with your doctor, you should decide whether to discontinue breast-feeding or discontinue treatment with Trifarotene, taking into account the benefit of breast-feeding for the child and the benefit of therapy for the mother. To avoid the risk of ingestion and/or exposure of the child, breast-feeding women should not apply Trifarotene to the chest or breast area.
• Reactions such as redness, peeling, dryness, and stinging/burning may occur with the use of Trifarotene cream. Talk to your doctor if this happens. The use of a moisturiser is recommended from the start of treatment, which is expected to help prevent these reactions. If symptoms occur, your doctor may advise you to use a moisturiser (if you have not already done so), reduce the frequency of Trifarotene application, or discontinue its use for a short period of time. If symptoms persist despite these measures, it may be necessary to discontinue Trifarotene completely.
• Trifarotene should not be used on areas with cuts, scratches, skin abrasions, or eczema.
• Trifarotene should not come into contact with the eyes, eyelids, lips, or mucous membranes. If the medicine accidentally comes into contact with the eyes, wash immediately and thoroughly with warm water. Exercise caution when using Trifarotene on sensitive skin areas such as the neck or axillae.
• Exercise caution when using Trifarotene cream concurrently with other skin preparations, including cosmetics.
• Waxing should not be used as a method of hair removal on skin treated with Trifarotene. If a reaction suggestive of sensitivity to any component of the formulation occurs, use of Trifarotene should be discontinued.
• Trifarotene should not be used on sunburned skin. Excessive sun exposure, including sunbeds or phototherapy, should be avoided during treatment. The use of a sunscreen with a sun protection factor (SPF) of 30 or higher and protective clothing (such as a hat and a top) on treated areas is recommended if sun exposure cannot be avoided. However, if your face, chest, shoulders, or back become sunburned, discontinue treatment on the affected areas until the skin has recovered.
